Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.77
-0.43 (-0.87%)
At close: Apr 6, 2026, 4:00 PM EDT
48.85
+0.08 (0.16%)
After-hours: Apr 6, 2026, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $19.34 billion as of April 6, 2026. Its market cap has increased by 50.14% in one year.
Market Cap
19.34B
Enterprise Value
12.51B
1-Year Change
50.14%
Ranking
Category
Stock Price
$48.77
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $19.34B, an increase of 216.12%. That is a compound annual growth rate of 17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 19.51B | 69.34% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 28.02B |
| BioNTech SE | 21.88B |
| Roivant Sciences | 20.28B |
| Revolution Medicines | 19.64B |
| Incyte | 19.09B |
| Genmab | 16.77B |
| Summit Therapeutics | 15.03B |
| BridgeBio Pharma | 14.18B |